OCD drug designed by artificial intelligence

#AI and #ML have so many unexplored opportunities for #startups to help big Pharma companies to reduce the time to discover new drugs.

Read an example

Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder (OCD) designed by artificial intelligence.

British #startup Exscientia and Japan’s Sumitomo Dainippon Pharma used artificial intelligence to create the drug in less than 12 months, cutting four years from the average time it takes ordinary humans to develop a medication.

Read on

'Cutting-edge science': OCD drug designed by artificial intelligence

Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder designed by artificial intelligence. British startup Exscientia and Japan's Sumitomo Dainippon Pharma used artificial intelligence to create the drug in less than 12 months, cutting four years from the average time it takes ordinary humans to develop a medication.